Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 112

1.

Severity of manchineel fruit (Hippomane mancinella) poisoning: A retrospective case series of 97 patients from French Poison Control Centers.

Denis BM, Xavier C, Chouaha B, Ludivine RV, Caroline D, Robert G, Jérôme L.

Toxicon. 2019 Apr 1;161:28-32. doi: 10.1016/j.toxicon.2019.02.014. Epub 2019 Feb 28.

PMID:
30826471
2.

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.

Ot'alora G M, Grigsby J, Poulter B, Van Derveer JW 3rd, Giron SG, Jerome L, Feduccia AA, Hamilton S, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R.

J Psychopharmacol. 2018 Dec;32(12):1295-1307. doi: 10.1177/0269881118806297. Epub 2018 Oct 29.

3.

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study.

Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L, Yazar-Klosinski B, Emerson A.

Psychopharmacology (Berl). 2018 Nov;235(11):3137-3148. doi: 10.1007/s00213-018-5010-9. Epub 2018 Sep 8.

4.

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.

Mithoefer MC, Mithoefer AT, Feduccia AA, Jerome L, Wagner M, Wymer J, Holland J, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R.

Lancet Psychiatry. 2018 Jun;5(6):486-497. doi: 10.1016/S2215-0366(18)30135-4. Epub 2018 May 1.

PMID:
29728331
5.

Response to the Consensus Statement of the PTSD Psychopharmacology Working Group.

Feduccia AA, Mithoefer MC, Jerome L, Holland J, Emerson A, Doblin R.

Biol Psychiatry. 2018 Jul 15;84(2):e21-e22. doi: 10.1016/j.biopsych.2017.11.023. Epub 2017 Nov 23. No abstract available.

PMID:
29279203
6.

Post-Traumatic Stress Disorder.

Mithoefer MC, Jerome L, Monson C.

N Engl J Med. 2017 Nov 2;377(18):1796-7. doi: 10.1056/NEJMc1709522. No abstract available.

PMID:
29094865
7.

Undiagnosed attention deficit/hyperactivity disorder (ADHD) among unionized drivers in Ghana: Public health and policy implications.

Ulzen TP, Higginbotham JC, Donnir G, Jerome L, Segal A.

Accid Anal Prev. 2018 May;114:12-16. doi: 10.1016/j.aap.2017.07.015. Epub 2017 Jul 22.

PMID:
28739027
8.

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.

Wagner MT, Mithoefer MC, Mithoefer AT, MacAulay RK, Jerome L, Yazar-Klosinski B, Doblin R.

J Psychopharmacol. 2017 Aug;31(8):967-974. doi: 10.1177/0269881117711712. Epub 2017 Jun 21.

9.

Increased rate of early smoking in children and adolescents with attention-deficit/hyperactivity disorder.

Jerome L.

CMAJ. 2017 May 29;189(21):E755. doi: 10.1503/cmaj.733013. No abstract available.

10.

Adult Attention-Deficit Hyperactivity Disorder is Hard to Diagnose and is Undertreated.

Jerome L.

Can J Psychiatry. 2016 Jan;61(1):59. doi: 10.1177/0706743715619937. No abstract available.

11.

The effects and determinants of exercise participation in first-episode psychosis: a qualitative study.

Firth J, Carney R, Jerome L, Elliott R, French P, Yung AR.

BMC Psychiatry. 2016 Feb 20;16:36. doi: 10.1186/s12888-016-0751-7.

12.

Drugged driving.

Jerome L.

CMAJ. 2015 Jun 16;187(9):681. doi: 10.1503/cmaj.1150041. No abstract available.

13.

Neurosurgery in Parkinson's disease: Social adjustment, quality of life and coping strategies.

Mylène M, Sébastien M, Sophie CC, Jérôme L, Jevita P, Pierre V, Nicolaie G, Hervé V, Gérard B, Elisabeth S, Raymund S.

Neural Regen Res. 2013 Oct 25;8(30):2856-67. doi: 10.3969/j.issn.1673-5374.2013.30.008. Review.

14.

Effects of methylphenidate on acute Math performance in children with ADHD.

Jerome L.

Can J Psychiatry. 2014 May;59(5):290. No abstract available.

PMID:
25026642
15.

The benefit of stimulants in reducing driving risk in adult drivers with ADHD.

Jerome L.

CMAJ. 2014 Jun 10;186(9):698. doi: 10.1503/cmaj.114-0044. No abstract available.

16.

History and future of the Multidisciplinary Association for Psychedelic Studies (MAPS).

Emerson A, Ponté L, Jerome L, Doblin R.

J Psychoactive Drugs. 2014 Jan-Mar;46(1):27-36.

PMID:
24830183
17.

A reconsideration and response to Parrott AC (2013) "Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research".

Doblin R, Greer G, Holland J, Jerome L, Mithoefer MC, Sessa B.

Hum Psychopharmacol. 2014 Mar;29(2):105-8. doi: 10.1002/hup.2389.

PMID:
24590541
18.

Prescription stimulant misuse among adolescent at-risk groups in Canada.

Jerome L.

Can J Psychiatry. 2013 May;58(5):308. No abstract available.

PMID:
23802247
19.

Can MDMA play a role in the treatment of substance abuse?

Jerome L, Schuster S, Yazar-Klosinski BB.

Curr Drug Abuse Rev. 2013 Mar;6(1):54-62. Review.

PMID:
23627786
20.

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R.

J Psychopharmacol. 2013 Jan;27(1):28-39. doi: 10.1177/0269881112456611. Epub 2012 Nov 20.

21.

Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes status.

Lo B, Swafford AD, Shafer-Weaver KA, Jerome LF, Rakhlin L, Mathern DR, Callahan CA, Jiang P, Davison LJ, Stevens HE, Lucas CL, White J, von Borstel R, Todd JA, Lenardo MJ.

J Transl Med. 2011 Nov 28;9:203. doi: 10.1186/1479-5876-9-203.

22.

Genome duplications within the Xenopodinae do not increase the multiplicity of antimicrobial peptides in Silurana paratropicalis and Xenopus andrei skin secretions.

Mechkarska M, Eman A, Coquet L, Jérôme L, Jouenne T, Vaudry H, King JD, Takada K, Conlon JM.

Comp Biochem Physiol Part D Genomics Proteomics. 2011 Jun;6(2):206-12. doi: 10.1016/j.cbd.2011.03.003. Epub 2011 Apr 4.

PMID:
21498136
23.

The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.

Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R.

J Psychopharmacol. 2011 Apr;25(4):439-52. doi: 10.1177/0269881110378371. Epub 2010 Jul 19. Erratum in: J Psychopharmacol. 2011 Jun;25(6):852.

24.

Psychophysiological arousal and craving in smokers, deprived smokers, former smokers, and non-smokers.

Jerome LW, Jordan PJ, Rodericks R, Fedenczuk L.

Stud Health Technol Inform. 2009;144:179-83.

PMID:
19592759
25.

Industry roundtable for interoperability and business process.

Jerome LW, Wong KH.

Mil Med. 2009 May;174(5 Suppl):51-5.

PMID:
19562962
26.

Importance of psychiatric confounding in non-randomized studies of heavy ecstasy users.

Krebs TS, Johansen PØ, Jerome L, Halpern JH.

Psychol Med. 2009 May;39(5):876-8. doi: 10.1017/S0033291708005096. Epub 2009 Feb 12. No abstract available.

PMID:
19215629
27.
28.

Case report: body piercing and reduction of repetitive self-injury.

Jerome L.

Can Child Adolesc Psychiatr Rev. 2003 Mar;12(2):44. No abstract available.

29.

Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models.

Alami N, Page V, Yu Q, Jerome L, Paterson J, Shiry L, Leyland-Jones B.

Growth Horm IGF Res. 2008 Dec;18(6):487-96. doi: 10.1016/j.ghir.2008.04.002. Epub 2008 May 23.

PMID:
18502161
30.

Teaching children to ignore teasing: A cognitive behavioural family strategy for dealing with teasing and reactive bullying.

Jerome L.

J Can Acad Child Adolesc Psychiatry. 2006 May;15(2):91. No abstract available.

31.

What we know about ADHD and driving risk: a literature review, meta-analysis and critique.

Jerome L, Segal A, Habinski L.

J Can Acad Child Adolesc Psychiatry. 2006 Aug;15(3):105-25.

32.

Re: Long-acting stimulants for novice drivers with ADHD.

Jerome L.

Can J Psychiatry. 2007 Sep;52(9):614. No abstract available.

PMID:
17953166
33.
34.

Novice drivers with attention-deficit hyperactivity disorder.

Jerome L.

CMAJ. 2007 Jun 5;176(12):1735. No abstract available.

35.

First case of sialolithiasis associated with atomoxetine.

Jerome L, Gardner D, Kutcher SP.

J Clin Psychopharmacol. 2007 Feb;27(1):111-2. No abstract available.

PMID:
17224735
36.

A needs assessment of chronic pain in psychiatric practice.

Jerome L.

Pain Res Manag. 2006 Autumn;11(3):200. No abstract available.

PMID:
17019795
37.

Attention-deficit/hyperactivity disorder (ADHD) and driving risk: a review of the literature and a methodological critique.

Jerome L, Habinski L, Segal A.

Curr Psychiatry Rep. 2006 Oct;8(5):416-26. Review.

PMID:
16968625
38.

Preclinical characterization of AEG35156/GEM 640, a second-generation antisense oligonucleotide targeting X-linked inhibitor of apoptosis.

LaCasse EC, Cherton-Horvat GG, Hewitt KE, Jerome LJ, Morris SJ, Kandimalla ER, Yu D, Wang H, Wang W, Zhang R, Agrawal S, Gillard JW, Durkin JP.

Clin Cancer Res. 2006 Sep 1;12(17):5231-41.

39.
40.

Re: Motivation and mechanism in motor vehicle collisions.

Jerome L, Segal A, Quinn D.

Can J Psychiatry. 2006 Jun;51(7):476. No abstract available.

PMID:
16838830
41.

The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy.

Sumnall HR, Cole JC, Jerome L.

J Psychopharmacol. 2006 Sep;20(5):670-82. Epub 2006 Jan 9.

PMID:
16401654
42.

Determination and documentation of the need for practice guidelines.

Sturm CA, Hancock KA, Cerbone AR, de La Cancela V, Connell MA, Foote WE, Galietta MM, James LC, Jerome LW, Knight SJ, Mohr DC, West CM, Witt PH; American Psychological Association; Committee on Professional Practice and Standards.

Am Psychol. 2005 Dec;60(9):976-8. No abstract available.

PMID:
16366819
43.

Forensic risk assessment and dangerous driving.

Jerome L.

Can J Psychiatry. 2005 Oct;50(11):739-40; author reply 740. No abstract available.

PMID:
16363467
44.

The effects of stereotype threat on cognitive function in ecstasy users.

Cole JC, Michailidou K, Jerome L, Sumnall HR.

J Psychopharmacol. 2006 Jul;20(4):518-25. Epub 2005 Sep 20.

PMID:
16174670
45.

Is ecstasy perceived to be safe? A critical survey.

Gamma A, Jerome L, Liechti ME, Sumnall HR.

Drug Alcohol Depend. 2005 Feb 14;77(2):185-93.

PMID:
15664720
46.

Road rage: old wine in a new bottle.

Jerome L.

Can J Psychiatry. 2004 Oct;49(10):709-10; author reply 710-1. No abstract available.

PMID:
15560323
47.

Ecstasy use-Parkinson's disease link tenuous.

Jerome L, Doblin R, Mithoefer M.

Mov Disord. 2004 Nov;19(11):1386. No abstract available.

PMID:
15389978
48.

Exposure to glycol ethers in a population of French men evaluated by measurement of urinary alkoxycarboxylic acids.

Ben-Brik E, Jérôme L, Arnaud I, Yous S, Labat L, Haguenoer JM, Multigner L.

Int Arch Occup Environ Health. 2004 Jun;77(5):368-72. Epub 2004 May 26.

PMID:
15164289
49.

Anti-insulin-like growth factor strategies in breast cancer.

Jerome L, Shiry L, Leyland-Jones B.

Semin Oncol. 2004 Feb;31(1 Suppl 3):54-63. Review.

PMID:
15052543
50.

Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions.

Jerome L, Shiry L, Leyland-Jones B.

Endocr Relat Cancer. 2003 Dec;10(4):561-78. Review.

PMID:
14713267

Supplemental Content

Loading ...
Support Center